Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · May 23, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding pituitary diseases, which are conditions affecting the pituitary gland located at the base of the brain. Researchers at Peking Union Medical College Hospital want to learn more about how these diseases affect patients, including what factors might influence their recovery, any other health issues they might have, and the outcomes of surgeries or treatments. They will look at different groups of patients who have been diagnosed with rare pituitary-related conditions, like specific types of tumors and cysts, to see how their experiences differ.

To take part in this study, participants need to have a diagnosis of certain rare pituitary diseases and a complete medical history. They will undergo thorough evaluations, share their medical information, and attend follow-up visits to track their health over time. This study is currently looking for individuals of all ages and genders who meet the eligibility criteria, and it aims to gather valuable information that could help improve understanding and treatment of these complex diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with rare sellar diseases including but not limited to pituitary adenomas (such as Thyrotropin-secreting pituitary adenomas, GH-secreting adenomas), craniopharyngiomas, Rathke's cleft cysts, sellar region germ cell tumors, cavernous sinus syndrome, and other diseases
• • Detailed medical history, including clinical symptoms, treatment plans and follow-up outcomes
• Exclusion Criteria:
• • Incomplete medical records, especially missing key imaging diagnostic results
• • Patients with coexisting primary central nervous system diseases unrelated to sellar region diseases (such as severe traumatic brain injury)
• • Patients whose sellar region pathological diagnosis was changed or overturned during the follow-up period

Trial Officials